Skip to main content
. 2019 Dec 22;25:9844–9854. doi: 10.12659/MSM.916820

Figure 3.

Figure 3

LINC01125 overexpression significantly enhanced the chemosensitivity of CDDP-resistant cells to CDDP and Taxol. (A, C) Viability curves of LINC01125-overexpressing SKOV-3/CDDP cells treated with different doses of CDDP (12.5, 25, 50, 100, 200, and 400 μM) and Taxol (1.25, 2.50, 5, 10, 20, and 40 μM) (* P<0.05). (B, D) Viability curves of LINC01125-overexpressing A2780/CDDP cells treated with different doses of CDDP (12.5, 25, 50, 100, 200, and 400 μM) and Taxol (1.25, 2.50, 5, 10, 20, and 40 μM) (* P<0.05). (E, F) The half maximal inhibitory concentration (IC50) of CDDP and Taxol in SKOV-3/CDDP and A2780/CDDP cells treated with LINC01125 (* P<0.05).